Novel method to spot melanoma may save lives

Novel method to spot melanoma may save lives

Researchers analyze molecular characteristics of cerebrospinal fluid from LMM patients Just like any other type of cancer, early detection and diagnosis are the keys to improving a patient’s health outcome or prognosis. If the cancer is detected at its early stages, it’s easier to treat. But, for cancers that have metastasized in other parts of the body, particularly vital organs, it’s harder to treat. Melanoma CTCs have been very elusive and hard to detect. Detecting these circulating cancer cells may vary between 40 and 87 percent, making diagnosis harder than expected. The researchers believe that CTCs have many differences, especially when it comes to their bioactivity and shape. Hence, these cancer cells may respond to assays differently. What’s more, these CTCs tend to hide among thousands of other cells, particularly in the blood. In fact, in one milliliter of blood, there are less than ten cancer cells among billions of red blood cells and white blood cells. Detecting these cancer cells is akin to finding a needle in a haystack. New approach shows promise Thanks to the work of scientists, they developed a new way to detect melanoma CTCs in the blood, providing a faster and more accurate way of diagnosing skin cancer. They studied the complexity of finding CTCs in the blood and decided they can’t use a one-size-fits-all approach. The team combined three assays together, boosting the rates of detection to a staggering 72 percent. The rate is higher than using just one test. “Our analysis revealed an extraordinary heterogeneity amongst melanoma CTCs, with multiple non-overlapping subpopulations. CTC detection using our multimarker approach was associated with shorter overall and progression-free survival. Finally, we found that CTC scores correlated with plasma ctDNA concentrations and had similar pharmacodynamic changes upon treatment initiation,” the team concluded in the study. The team believes that the new approach will pave the way to develop reliable detection of CTCs. However, they want to further polish their diagnostic test to capture the broadest range of CTCs. Detecting these cancer cells early can improve survival rates and may lead to a better quality of life. Journal reference: Aya-Bonilla, C.A., Morici, M., Hong, X. et al. Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells. Br J Cancer (2020). https://doi.org/10.1038/s41416-020-0750-9



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More